Coronary CT angiography derived FFR in patients with left main disease

The presence of left main coronary artery disease (LMCAD) is associated with an unfavorable clinical outcome. The clinical utility of FFRCTtesting for non-invasive physiological assessment in LMCAD remains largely unknown. In this single center observational study LMCAD patients were retrospectively identified between November 2015 and December 2017. We evaluated the relationship between LMCAD diameter stenosis and downstream FFRCTvalues, and the clinical consequences following FFRCTtesting in patients with LMCAD. The composite endpoint (all-cause death, myocardial infarction, unplanned revascularization) was determined over a median follow-up of 1.1 years. LMCAD was registered in 432 of 3202 (13%) patients having coronary CTA. FFRCTwas prescribed in 213 (49%), while 59 (14%) patients were referred directly to invasive angiography or myocardial perfusion imaging. FFRCTwas performed in 195 (45%) patients. LM stenosis severity was inversely related to downstream FFRCTvalues. In patients with simple LMCAD with stenosis ≥ 50%, > 80% had FFRCT> 0.80 in non-diseased proximal and downstream segments (n = 7). No patients with simple LMCAD and FFRCT > 0.80 (n = 20) suffered an adverse clinical outcome. FFRCTtesting in patients with LMCAD is feasible. LM stenosis severity is inversely related to FFRCTvalue. Patients with LMCAD and FFRCT > 0.80 have favorable clinical outcomes at short-term follow-up. Large-scale studies assessing the clinical utility and safety of deferring invasive catheterization following FFRCTtesting in patients with LMCAD are warranted.